TCBPW Property Plant And Equipment Net vs Total Current Liabilities Analysis

TCBPW Stock  USD 0.01  0.0007  5.22%   
TC BioPharm financial indicator trend analysis is much more than just breaking down TC BioPharm plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TC BioPharm plc is a good investment. Please check the relationship between TC BioPharm Property Plant And Equipment Net and its Total Current Liabilities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Property Plant And Equipment Net vs Total Current Liabilities

Property Plant And Equipment Net vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TC BioPharm plc Property Plant And Equipment Net account and Total Current Liabilities. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between TC BioPharm's Property Plant And Equipment Net and Total Current Liabilities is -0.49. Overlapping area represents the amount of variation of Property Plant And Equipment Net that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of TC BioPharm plc, assuming nothing else is changed. The correlation between historical values of TC BioPharm's Property Plant And Equipment Net and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Net of TC BioPharm plc are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Property Plant And Equipment Net i.e., TC BioPharm's Property Plant And Equipment Net and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

-0.49
Relationship DirectionNegative 
Relationship StrengthVery Weak

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Total Current Liabilities

Total Current Liabilities is an item on TC BioPharm balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of TC BioPharm plc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from TC BioPharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TC BioPharm plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Tax Provision is likely to drop to about (1 M) in 2025. Selling General Administrative is likely to drop to about 5.1 M in 2025
 2022 2024 2025 (projected)
Depreciation And Amortization762.5K567.1K638.0K
Interest Income2.2K2.0K1.9K

TC BioPharm fundamental ratios Correlations

-0.45-0.3-0.350.480.18-0.02-0.50.18-0.20.310.17-0.440.310.49-0.050.130.05-0.540.460.1-0.290.42-0.040.610.11
-0.450.580.82-0.94-0.010.330.96-0.110.1-0.14-0.010.68-0.14-0.09-0.30.010.170.11-0.480.040.91-0.810.13-0.28-0.15
-0.30.580.92-0.38-0.67-0.30.35-0.750.470.63-0.670.920.63-0.70.27-0.71-0.550.71-0.480.60.41-0.15-0.540.32-0.74
-0.350.820.92-0.63-0.49-0.140.66-0.590.410.35-0.490.920.35-0.510.14-0.51-0.320.52-0.390.510.67-0.4-0.40.13-0.62
0.48-0.94-0.38-0.63-0.27-0.61-0.96-0.190.20.36-0.28-0.450.36-0.130.57-0.29-0.450.090.620.29-0.950.96-0.380.51-0.17
0.18-0.01-0.67-0.49-0.270.880.20.98-0.9-0.781.0-0.73-0.780.93-0.840.990.98-0.91-0.09-0.90.32-0.520.76-0.640.97
-0.020.33-0.3-0.14-0.610.880.470.85-0.85-0.630.89-0.38-0.630.74-0.980.870.93-0.71-0.52-0.890.6-0.80.8-0.640.85
-0.50.960.350.66-0.960.20.470.11-0.05-0.420.20.48-0.420.08-0.40.230.38-0.05-0.41-0.160.92-0.890.27-0.510.07
0.18-0.11-0.75-0.59-0.190.980.850.11-0.87-0.780.98-0.79-0.780.89-0.810.990.94-0.89-0.07-0.930.2-0.450.77-0.620.99
-0.20.10.470.410.2-0.9-0.85-0.05-0.870.56-0.90.670.56-0.790.83-0.84-0.880.760.30.86-0.290.43-0.610.56-0.89
0.31-0.140.630.350.36-0.78-0.63-0.42-0.780.56-0.780.521.0-0.60.51-0.83-0.820.58-0.060.75-0.310.54-0.590.89-0.77
0.17-0.01-0.67-0.49-0.281.00.890.20.98-0.9-0.78-0.72-0.780.92-0.850.990.98-0.91-0.11-0.910.32-0.530.78-0.640.97
-0.440.680.920.92-0.45-0.73-0.380.48-0.790.670.52-0.720.52-0.740.36-0.72-0.590.75-0.340.660.4-0.18-0.450.28-0.8
0.31-0.140.630.350.36-0.78-0.63-0.42-0.780.561.0-0.780.52-0.60.51-0.83-0.820.58-0.060.75-0.310.54-0.590.89-0.77
0.49-0.09-0.7-0.51-0.130.930.740.080.89-0.79-0.60.92-0.74-0.6-0.740.910.87-1.00.13-0.720.23-0.350.7-0.330.85
-0.05-0.30.270.140.57-0.84-0.98-0.4-0.810.830.51-0.850.360.51-0.74-0.82-0.880.70.570.86-0.570.76-0.830.53-0.81
0.130.01-0.71-0.51-0.290.990.870.230.99-0.84-0.830.99-0.72-0.830.91-0.820.97-0.9-0.07-0.910.3-0.540.81-0.660.97
0.050.17-0.55-0.32-0.450.980.930.380.94-0.88-0.820.98-0.59-0.820.87-0.880.97-0.85-0.2-0.890.49-0.670.77-0.720.93
-0.540.110.710.520.09-0.91-0.71-0.05-0.890.760.58-0.910.750.58-1.00.7-0.9-0.85-0.180.69-0.190.31-0.670.3-0.83
0.46-0.48-0.48-0.390.62-0.09-0.52-0.41-0.070.3-0.06-0.11-0.34-0.060.130.57-0.07-0.2-0.180.37-0.520.63-0.330.3-0.15
0.10.040.60.510.29-0.9-0.89-0.16-0.930.860.75-0.910.660.75-0.720.86-0.91-0.890.690.37-0.230.55-0.830.74-0.97
-0.290.910.410.67-0.950.320.60.920.2-0.29-0.310.320.4-0.310.23-0.570.30.49-0.19-0.52-0.23-0.910.27-0.440.16
0.42-0.81-0.15-0.40.96-0.52-0.8-0.89-0.450.430.54-0.53-0.180.54-0.350.76-0.54-0.670.310.630.55-0.91-0.580.66-0.44
-0.040.13-0.54-0.4-0.380.760.80.270.77-0.61-0.590.78-0.45-0.590.7-0.830.810.77-0.67-0.33-0.830.27-0.58-0.50.79
0.61-0.280.320.130.51-0.64-0.64-0.51-0.620.560.89-0.640.280.89-0.330.53-0.66-0.720.30.30.74-0.440.66-0.5-0.66
0.11-0.15-0.74-0.62-0.170.970.850.070.99-0.89-0.770.97-0.8-0.770.85-0.810.970.93-0.83-0.15-0.970.16-0.440.79-0.66
Click cells to compare fundamentals

TC BioPharm Account Relationship Matchups

TC BioPharm fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets7.3M8.0M11.3M8.9M10.3M10.0M
Short Long Term Debt Total2.6M15.9M2.5M1.8M1.6M1.5M
Other Current Liab3.1M9.6M7.3M2.5M2.8M5.1M
Total Current Liabilities4.2M20.6M9.2M4.8M5.5M9.4M
Total Stockholder Equity(3.3M)(16.6M)331.3K2.7M3.1M3.2M
Property Plant And Equipment Net4.6M3.7M3.3M2.6M2.4M3.2M
Current Deferred Revenue2.0M2.0M1.3M(305.3K)(274.8K)(261.1K)
Net Debt1.8M14.3M(2.4M)(661.5K)(595.3K)(565.5K)
Retained Earnings(19.9M)(33.5M)(33.4M)(38.8M)(35.0M)(36.7M)
Accounts Payable638.4K1.4M882.4K1.8M2.1M1.2M
Cash748.0K1.6M4.8M2.5M2.8M2.3M
Non Current Assets Total5.0M4.2M3.8M3.2M2.9M3.6M
Cash And Short Term Investments748.0K1.6M4.8M2.5M2.8M2.3M
Net Receivables1.2M1.5M1.8M1.2M1.1M1.4M
Common Stock Shares Outstanding11.2M7.8M13.7M123.6M142.1M149.2M
Liabilities And Stockholders Equity7.3M8.0M11.3M8.9M10.3M10.0M
Non Current Liabilities Total6.4M4.0M1.8M1.5M1.3M1.3M
Capital Lease Obligations3.0M2.9M2.1M1.8M1.6M2.1M
Inventory(1.2M)(1.5M)(1.8M)(1.2M)(1.4M)(1.5M)
Other Current Assets230.7K811.3K836.1K4.1M4.7M4.9M
Total Liab10.6M24.6M11.0M6.2M5.6M10.4M
Net Invested Capital(3.3M)(9.8M)627.8K2.7M3.1M3.2M
Property Plant And Equipment Gross6.9M6.7M6.5M6.8M6.1M5.4M
Total Current Assets2.2M3.9M7.4M5.7M6.6M5.2M
Capital Stock1.8M195.5K397.5K2.1K1.9K1.8K
Net Working Capital(2.0M)(16.7M)(1.7M)950.3K1.1M1.1M
Short Term Debt442.7K7.6M981.5K305.3K351.1K333.6K
Intangible Assets423.8K483.6K553.0K615.2K707.4K523.9K
Common Stock194.6K195.5K397.5K2.1K1.9K1.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.